🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hepatitis A vaccine will be given either alone or together with measles, mu...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00312858
Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clin...
Status
Completed
Location
Jiangsu Province Center for Disease Control and Prevention
Start Date
2020-04-20
Trial ID
NCT04334577
Treatments Being Tested
The purpose of this study was to evaluate the immunogenicity and safety of ...
Status
Completed
Location
Republican Clinical Infectious Hospital n.a. A.F. Agafonov ( Site 5816)
Start Date
2019-03-01
Trial ID
NCT03843632
Treatments Being Tested
A study in two parts (Part A and Part B) to evaluate the responsiveness of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00886613
Treatments Being Tested
This is Phase 4 clinical trial of live attenuated varicella vaccines manufa...
Status
Unknown
Location
Susong County Center for Disease Control and Prevention
Start Date
2022-07-06
Trial ID
NCT05470855
Treatments Being Tested
This study will evaluate the ability of the vaccine to produce antibodies a...
Status
Terminated
Location
Inno-6041 study site
Start Date
2016-06
Trial ID
NCT02408159
Treatments Being Tested
The main target populations for the tetravalent live attenuated dengue viru...
Status
Completed
Location
USAMC-AFRIMS/Department of Pediatrics, Pharamongkutklao Hospital
Start Date
2004-02
Trial ID
NCT00322049
Primary objective: To demonstrate whether or not ZOSTAVAX® at minimum rele...
Status
Completed
Location
Multiple Locations
Start Date
2008-05-14
Trial ID
NCT00681031
Treatments Being Tested
The purpose of this study is to compare two measles, mumps and rubella conj...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-03
Trial ID
NCT00861744
The purpose of the study is to evaluate the immunogenicity and safety of Ki...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-31
Trial ID
NCT00871117
Treatments Being Tested